APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-animal Capsule

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-animal Capsule Market Outlook and Growth Opportunities 2026

19 December 2025206 pages

Choose your research edition.

Industry ResearchNon-animal Capsule Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-animal Capsule Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Non-animal Capsule Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-animal Capsule Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-animal Capsule Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Non-animal Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-animal Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-animal Capsule market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-animal Capsule market include Qingdao Capsule, Lonza (Capsugel), Shanxi GS Capsule, Sunil Healthcare, Suheung Capsule, SIRIO, Robinson Pharma, Qualicaps and Procaps Laboratorios, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non-animal Capsule market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-animal Capsule and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-animal Capsule sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non-animal Capsule market size, projected growth trends, production technologies, key applications, and end-use industries.

Non-animal Capsule Segment by Company

Qingdao Capsule

Lonza (Capsugel)

Shanxi GS Capsule

Sunil Healthcare

Suheung Capsule

SIRIO

Robinson Pharma

Qualicaps

Procaps Laboratorios

Lefan Capsule

Eurocaps

Er-kang

Catalent

Captek

CapsCanada

Best Formulations

Bahrain Pharma

Aenova

ACG Associated Capsules

Non-animal Capsule Segment by Type

HPMC

Starch

Plant Polysaccharides

Others

Non-animal Capsule Segment by Application

Pharmaceutical

Health Supplements

Others

Non-animal Capsule Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Non-animal Capsule status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non-animal Capsule market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-animal Capsule significant trends, drivers, influence factors in global and regions.

6. To analyze Non-animal Capsule competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-animal Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-animal Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-animal Capsule.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non-animal Capsule market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-animal Capsule industry.

Chapter 3: Detailed analysis of Non-animal Capsule manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non-animal Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non-animal Capsule in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-animal Capsule Industry Trends Table 2. Non-animal Capsule Industry Drivers Table 3. Non-animal Capsule Industry Opportunities and Challenges Table 4. Non-animal Capsule Industry Restraints Table 5. Global Non-animal Capsule Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-animal Capsule Revenue Share by Company (2021-2026) Table 7. Global Non-animal Capsule Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Non-animal Capsule Sales Volume Share by Company (2021-2026) Table 9. Global Non-animal Capsule Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Non-animal Capsule Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non-animal Capsule Key Company Manufacturing Base & Headquarters Table 12. Global Non-animal Capsule Company, Product Type & Application Table 13. Global Non-animal Capsule Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non-animal Capsule by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of HPMC Table 18. Significant Companies of Starch Table 19. Significant Companies of Plant Polysaccharides Table 20. Significant Companies of Others Table 21. Global Non-animal Capsule Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Non-animal Capsule Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Non-animal Capsule Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Non-animal Capsule Sales Volume Share by Type (2021-2026) Table 25. Global Non-animal Capsule Sales Volume Share by Type (2027-2032) Table 26. Global Non-animal Capsule Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Non-animal Capsule Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Non-animal Capsule Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Non-animal Capsule Sales Value Share by Type (2021-2026) Table 30. Global Non-animal Capsule Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Pharmaceutical Table 32. Significant Companies of Health Supplements Table 33. Significant Companies of Others Table 34. Global Non-animal Capsule Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 35. Global Non-animal Capsule Sales Volume by Application (2021-2026) & (W Units) Table 36. Global Non-animal Capsule Sales Volume by Application (2027-2032) & (W Units) Table 37. Global Non-animal Capsule Sales Volume Share by Application (2021-2026) Table 38. Global Non-animal Capsule Sales Volume Share by Application (2027-2032) Table 39. Global Non-animal Capsule Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Non-animal Capsule Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Non-animal Capsule Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Non-animal Capsule Sales Value Share by Application (2021-2026) Table 43. Global Non-animal Capsule Sales Value Share by Application (2027-2032) Table 44. Global Non-animal Capsule Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 45. Global Non-animal Capsule Sales by Region (2021-2026) & (W Units) Table 46. Global Non-animal Capsule Sales Market Share by Region (2021-2026) Table 47. Global Non-animal Capsule Sales by Region (2027-2032) & (W Units) Table 48. Global Non-animal Capsule Sales Market Share by Region (2027-2032) Table 49. Global Non-animal Capsule Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Non-animal Capsule Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Non-animal Capsule Sales Value Share by Region (2021-2026) Table 52. Global Non-animal Capsule Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Non-animal Capsule Sales Value Share by Region (2027-2032) Table 54. Global Non-animal Capsule Market Average Price (US$/Unit) by Region (2021-2026) Table 55. Global Non-animal Capsule Market Average Price (US$/Unit) by Region (2027-2032) Table 56. Global Non-animal Capsule Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. Global Non-animal Capsule Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Non-animal Capsule Sales by Country (2021-2026) & (W Units) Table 59. Global Non-animal Capsule Sales Market Share by Country (2021-2026) Table 60. Global Non-animal Capsule Sales by Country (2027-2032) & (W Units) Table 61. Global Non-animal Capsule Sales Market Share by Country (2027-2032) Table 62. Global Non-animal Capsule Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Non-animal Capsule Sales Value Market Share by Country (2021-2026) Table 64. Global Non-animal Capsule Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Non-animal Capsule Sales Value Market Share by Country (2027-2032) Table 66. Qingdao Capsule Company Information Table 67. Qingdao Capsule Business Overview Table 68. Qingdao Capsule Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 69. Qingdao Capsule Non-animal Capsule Product Portfolio Table 70. Qingdao Capsule Recent Development Table 71. Lonza (Capsugel) Company Information Table 72. Lonza (Capsugel) Business Overview Table 73. Lonza (Capsugel) Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Lonza (Capsugel) Non-animal Capsule Product Portfolio Table 75. Lonza (Capsugel) Recent Development Table 76. Shanxi GS Capsule Company Information Table 77. Shanxi GS Capsule Business Overview Table 78. Shanxi GS Capsule Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Shanxi GS Capsule Non-animal Capsule Product Portfolio Table 80. Shanxi GS Capsule Recent Development Table 81. Sunil Healthcare Company Information Table 82. Sunil Healthcare Business Overview Table 83. Sunil Healthcare Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sunil Healthcare Non-animal Capsule Product Portfolio Table 85. Sunil Healthcare Recent Development Table 86. Suheung Capsule Company Information Table 87. Suheung Capsule Business Overview Table 88. Suheung Capsule Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Suheung Capsule Non-animal Capsule Product Portfolio Table 90. Suheung Capsule Recent Development Table 91. SIRIO Company Information Table 92. SIRIO Business Overview Table 93. SIRIO Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. SIRIO Non-animal Capsule Product Portfolio Table 95. SIRIO Recent Development Table 96. Robinson Pharma Company Information Table 97. Robinson Pharma Business Overview Table 98. Robinson Pharma Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Robinson Pharma Non-animal Capsule Product Portfolio Table 100. Robinson Pharma Recent Development Table 101. Qualicaps Company Information Table 102. Qualicaps Business Overview Table 103. Qualicaps Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Qualicaps Non-animal Capsule Product Portfolio Table 105. Qualicaps Recent Development Table 106. Procaps Laboratorios Company Information Table 107. Procaps Laboratorios Business Overview Table 108. Procaps Laboratorios Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Procaps Laboratorios Non-animal Capsule Product Portfolio Table 110. Procaps Laboratorios Recent Development Table 111. Lefan Capsule Company Information Table 112. Lefan Capsule Business Overview Table 113. Lefan Capsule Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Lefan Capsule Non-animal Capsule Product Portfolio Table 115. Lefan Capsule Recent Development Table 116. Eurocaps Company Information Table 117. Eurocaps Business Overview Table 118. Eurocaps Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Eurocaps Non-animal Capsule Product Portfolio Table 120. Eurocaps Recent Development Table 121. Er-kang Company Information Table 122. Er-kang Business Overview Table 123. Er-kang Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Er-kang Non-animal Capsule Product Portfolio Table 125. Er-kang Recent Development Table 126. Catalent Company Information Table 127. Catalent Business Overview Table 128. Catalent Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Catalent Non-animal Capsule Product Portfolio Table 130. Catalent Recent Development Table 131. Captek Company Information Table 132. Captek Business Overview Table 133. Captek Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Captek Non-animal Capsule Product Portfolio Table 135. Captek Recent Development Table 136. CapsCanada Company Information Table 137. CapsCanada Business Overview Table 138. CapsCanada Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. CapsCanada Non-animal Capsule Product Portfolio Table 140. CapsCanada Recent Development Table 141. Best Formulations Company Information Table 142. Best Formulations Business Overview Table 143. Best Formulations Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Best Formulations Non-animal Capsule Product Portfolio Table 145. Best Formulations Recent Development Table 146. Bahrain Pharma Company Information Table 147. Bahrain Pharma Business Overview Table 148. Bahrain Pharma Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Bahrain Pharma Non-animal Capsule Product Portfolio Table 150. Bahrain Pharma Recent Development Table 151. Aenova Company Information Table 152. Aenova Business Overview Table 153. Aenova Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Aenova Non-animal Capsule Product Portfolio Table 155. Aenova Recent Development Table 156. ACG Associated Capsules Company Information Table 157. ACG Associated Capsules Business Overview Table 158. ACG Associated Capsules Non-animal Capsule Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. ACG Associated Capsules Non-animal Capsule Product Portfolio Table 160. ACG Associated Capsules Recent Development Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Non-animal Capsule Distributors List Table 164. Non-animal Capsule Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Non-animal Capsule Product Image Figure 2. Global Non-animal Capsule Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-animal Capsule Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non-animal Capsule Sales (2021-2032) & (W Units) Figure 5. Global Non-animal Capsule Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Non-animal Capsule Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. HPMC Image Figure 10. Starch Image Figure 11. Plant Polysaccharides Image Figure 12. Others Image Figure 13. Global Non-animal Capsule Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Non-animal Capsule Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Non-animal Capsule Sales Volume Share by Type (2021-2032) Figure 16. Global Non-animal Capsule Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Non-animal Capsule Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Non-animal Capsule Sales Value Share by Type (2021-2032) Figure 19. Pharmaceutical Image Figure 20. Health Supplements Image Figure 21. Others Image Figure 22. Global Non-animal Capsule Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 23. Global Non-animal Capsule Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Non-animal Capsule Sales Volume Share by Application (2021-2032) Figure 25. Global Non-animal Capsule Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Non-animal Capsule Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Non-animal Capsule Sales Value Share by Application (2021-2032) Figure 28. Global Non-animal Capsule Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 29. Global Non-animal Capsule Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Non-animal Capsule Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Non-animal Capsule Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Non-animal Capsule Sales Value (2021-2032) & (US$ Million) Figure 33. North America Non-animal Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Non-animal Capsule Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Non-animal Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Non-animal Capsule Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Non-animal Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Non-animal Capsule Sales Value (2021-2032) & (US$ Million) Figure 39. South America Non-animal Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Non-animal Capsule Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Non-animal Capsule Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Non-animal Capsule Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Non-animal Capsule Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Non-animal Capsule Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Non-animal Capsule Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Non-animal Capsule Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • HPMC
  • Starch
  • Plant Polysaccharides
  • Others
Applications
  • Pharmaceutical
  • Health Supplements
  • Others
Companies covered
  • Qingdao Capsule
  • Lonza (Capsugel)
  • Shanxi GS Capsule
  • Sunil Healthcare
  • Suheung Capsule
  • SIRIO
  • Robinson Pharma
  • Qualicaps
  • Procaps Laboratorios
  • Lefan Capsule
  • Eurocaps
  • Er-kang
  • Catalent
  • Captek
  • CapsCanada
  • Best Formulations
  • Bahrain Pharma
  • Aenova
  • ACG Associated Capsules

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non-animal Capsule Sales Value (2021-2032)
  4. 1.2.2 Global Non-animal Capsule Sales Volume (2021-2032)
  5. 1.2.3 Global Non-animal Capsule Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non-animal Capsule Market Dynamics
  1. 2.1 Non-animal Capsule Industry Trends
  2. 2.2 Non-animal Capsule Industry Drivers
  3. 2.3 Non-animal Capsule Industry Opportunities and Challenges
  4. 2.4 Non-animal Capsule Industry Restraints
3 Non-animal Capsule Market by Company
  1. 3.1 Global Non-animal Capsule Company Revenue Ranking in 2025
  2. 3.2 Global Non-animal Capsule Revenue by Company (2021-2026)
  3. 3.3 Global Non-animal Capsule Sales Volume by Company (2021-2026)
  4. 3.4 Global Non-animal Capsule Average Price by Company (2021-2026)
  5. 3.5 Global Non-animal Capsule Company Ranking (2024-2026)
  6. 3.6 Global Non-animal Capsule Company Manufacturing Base and Headquarters
  7. 3.7 Global Non-animal Capsule Company Product Type and Application
  8. 3.8 Global Non-animal Capsule Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non-animal Capsule Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non-animal Capsule Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non-animal Capsule Market by Type
  1. 4.1 Non-animal Capsule Type Introduction
  2. 4.1.1 HPMC
  3. 4.1.2 Starch
  4. 4.1.3 Plant Polysaccharides
  5. 4.1.4 Others
  6. 4.2 Global Non-animal Capsule Sales Volume by Type
  7. 4.2.1 Global Non-animal Capsule Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Non-animal Capsule Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Non-animal Capsule Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Non-animal Capsule Sales Value by Type
  11. 4.3.1 Global Non-animal Capsule Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Non-animal Capsule Sales Value by Type (2021-2032)
  13. 4.3.3 Global Non-animal Capsule Sales Value Share by Type (2021-2032)
5 Non-animal Capsule Market by Application
  1. 5.1 Non-animal Capsule Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Health Supplements
  4. 5.1.3 Others
  5. 5.2 Global Non-animal Capsule Sales Volume by Application
  6. 5.2.1 Global Non-animal Capsule Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-animal Capsule Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Non-animal Capsule Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Non-animal Capsule Sales Value by Application
  10. 5.3.1 Global Non-animal Capsule Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Non-animal Capsule Sales Value by Application (2021-2032)
  12. 5.3.3 Global Non-animal Capsule Sales Value Share by Application (2021-2032)
6 Non-animal Capsule Regional Sales and Value Analysis
  1. 6.1 Global Non-animal Capsule Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-animal Capsule Sales by Region (2021-2032)
  3. 6.2.1 Global Non-animal Capsule Sales by Region: 2021-2026
  4. 6.2.2 Global Non-animal Capsule Sales by Region (2027-2032)
  5. 6.3 Global Non-animal Capsule Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non-animal Capsule Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non-animal Capsule Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non-animal Capsule Sales Value by Region (2027-2032)
  9. 6.5 Global Non-animal Capsule Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non-animal Capsule Sales Value (2021-2032)
  12. 6.6.2 North America Non-animal Capsule Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non-animal Capsule Sales Value (2021-2032)
  15. 6.7.2 Europe Non-animal Capsule Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non-animal Capsule Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non-animal Capsule Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non-animal Capsule Sales Value (2021-2032)
  21. 6.9.2 South America Non-animal Capsule Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non-animal Capsule Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non-animal Capsule Sales Value Share by Country, 2025 VS 2032
7 Non-animal Capsule Country-level Sales and Value Analysis
  1. 7.1 Global Non-animal Capsule Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-animal Capsule Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non-animal Capsule Sales by Country (2021-2032)
  4. 7.3.1 Global Non-animal Capsule Sales by Country (2021-2026)
  5. 7.3.2 Global Non-animal Capsule Sales by Country (2027-2032)
  6. 7.4 Global Non-animal Capsule Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non-animal Capsule Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non-animal Capsule Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non-animal Capsule Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non-animal Capsule Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non-animal Capsule Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non-animal Capsule Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non-animal Capsule Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non-animal Capsule Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non-animal Capsule Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non-animal Capsule Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non-animal Capsule Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non-animal Capsule Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non-animal Capsule Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non-animal Capsule Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non-animal Capsule Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non-animal Capsule Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non-animal Capsule Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non-animal Capsule Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non-animal Capsule Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non-animal Capsule Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non-animal Capsule Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non-animal Capsule Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non-animal Capsule Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non-animal Capsule Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non-animal Capsule Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non-animal Capsule Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non-animal Capsule Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non-animal Capsule Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non-animal Capsule Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non-animal Capsule Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non-animal Capsule Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non-animal Capsule Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Qingdao Capsule
  2. 8.1.1 Qingdao Capsule Company Information
  3. 8.1.2 Qingdao Capsule Business Overview
  4. 8.1.3 Qingdao Capsule Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Qingdao Capsule Non-animal Capsule Product Portfolio
  6. 8.1.5 Qingdao Capsule Recent Developments
  7. 8.2 Lonza (Capsugel)
  8. 8.2.1 Lonza (Capsugel) Company Information
  9. 8.2.2 Lonza (Capsugel) Business Overview
  10. 8.2.3 Lonza (Capsugel) Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Lonza (Capsugel) Non-animal Capsule Product Portfolio
  12. 8.2.5 Lonza (Capsugel) Recent Developments
  13. 8.3 Shanxi GS Capsule
  14. 8.3.1 Shanxi GS Capsule Company Information
  15. 8.3.2 Shanxi GS Capsule Business Overview
  16. 8.3.3 Shanxi GS Capsule Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shanxi GS Capsule Non-animal Capsule Product Portfolio
  18. 8.3.5 Shanxi GS Capsule Recent Developments
  19. 8.4 Sunil Healthcare
  20. 8.4.1 Sunil Healthcare Company Information
  21. 8.4.2 Sunil Healthcare Business Overview
  22. 8.4.3 Sunil Healthcare Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sunil Healthcare Non-animal Capsule Product Portfolio
  24. 8.4.5 Sunil Healthcare Recent Developments
  25. 8.5 Suheung Capsule
  26. 8.5.1 Suheung Capsule Company Information
  27. 8.5.2 Suheung Capsule Business Overview
  28. 8.5.3 Suheung Capsule Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Suheung Capsule Non-animal Capsule Product Portfolio
  30. 8.5.5 Suheung Capsule Recent Developments
  31. 8.6 SIRIO
  32. 8.6.1 SIRIO Company Information
  33. 8.6.2 SIRIO Business Overview
  34. 8.6.3 SIRIO Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 SIRIO Non-animal Capsule Product Portfolio
  36. 8.6.5 SIRIO Recent Developments
  37. 8.7 Robinson Pharma
  38. 8.7.1 Robinson Pharma Company Information
  39. 8.7.2 Robinson Pharma Business Overview
  40. 8.7.3 Robinson Pharma Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Robinson Pharma Non-animal Capsule Product Portfolio
  42. 8.7.5 Robinson Pharma Recent Developments
  43. 8.8 Qualicaps
  44. 8.8.1 Qualicaps Company Information
  45. 8.8.2 Qualicaps Business Overview
  46. 8.8.3 Qualicaps Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Qualicaps Non-animal Capsule Product Portfolio
  48. 8.8.5 Qualicaps Recent Developments
  49. 8.9 Procaps Laboratorios
  50. 8.9.1 Procaps Laboratorios Company Information
  51. 8.9.2 Procaps Laboratorios Business Overview
  52. 8.9.3 Procaps Laboratorios Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Procaps Laboratorios Non-animal Capsule Product Portfolio
  54. 8.9.5 Procaps Laboratorios Recent Developments
  55. 8.10 Lefan Capsule
  56. 8.10.1 Lefan Capsule Company Information
  57. 8.10.2 Lefan Capsule Business Overview
  58. 8.10.3 Lefan Capsule Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Lefan Capsule Non-animal Capsule Product Portfolio
  60. 8.10.5 Lefan Capsule Recent Developments
  61. 8.11 Eurocaps
  62. 8.11.1 Eurocaps Company Information
  63. 8.11.2 Eurocaps Business Overview
  64. 8.11.3 Eurocaps Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Eurocaps Non-animal Capsule Product Portfolio
  66. 8.11.5 Eurocaps Recent Developments
  67. 8.12 Er-kang
  68. 8.12.1 Er-kang Company Information
  69. 8.12.2 Er-kang Business Overview
  70. 8.12.3 Er-kang Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Er-kang Non-animal Capsule Product Portfolio
  72. 8.12.5 Er-kang Recent Developments
  73. 8.13 Catalent
  74. 8.13.1 Catalent Company Information
  75. 8.13.2 Catalent Business Overview
  76. 8.13.3 Catalent Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Catalent Non-animal Capsule Product Portfolio
  78. 8.13.5 Catalent Recent Developments
  79. 8.14 Captek
  80. 8.14.1 Captek Company Information
  81. 8.14.2 Captek Business Overview
  82. 8.14.3 Captek Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Captek Non-animal Capsule Product Portfolio
  84. 8.14.5 Captek Recent Developments
  85. 8.15 CapsCanada
  86. 8.15.1 CapsCanada Company Information
  87. 8.15.2 CapsCanada Business Overview
  88. 8.15.3 CapsCanada Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 CapsCanada Non-animal Capsule Product Portfolio
  90. 8.15.5 CapsCanada Recent Developments
  91. 8.16 Best Formulations
  92. 8.16.1 Best Formulations Company Information
  93. 8.16.2 Best Formulations Business Overview
  94. 8.16.3 Best Formulations Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Best Formulations Non-animal Capsule Product Portfolio
  96. 8.16.5 Best Formulations Recent Developments
  97. 8.17 Bahrain Pharma
  98. 8.17.1 Bahrain Pharma Company Information
  99. 8.17.2 Bahrain Pharma Business Overview
  100. 8.17.3 Bahrain Pharma Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Bahrain Pharma Non-animal Capsule Product Portfolio
  102. 8.17.5 Bahrain Pharma Recent Developments
  103. 8.18 Aenova
  104. 8.18.1 Aenova Company Information
  105. 8.18.2 Aenova Business Overview
  106. 8.18.3 Aenova Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 Aenova Non-animal Capsule Product Portfolio
  108. 8.18.5 Aenova Recent Developments
  109. 8.19 ACG Associated Capsules
  110. 8.19.1 ACG Associated Capsules Company Information
  111. 8.19.2 ACG Associated Capsules Business Overview
  112. 8.19.3 ACG Associated Capsules Non-animal Capsule Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 ACG Associated Capsules Non-animal Capsule Product Portfolio
  114. 8.19.5 ACG Associated Capsules Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non-animal Capsule Value Chain Analysis
  2. 9.1.1 Non-animal Capsule Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non-animal Capsule Sales Mode & Process
  6. 9.2 Non-animal Capsule Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non-animal Capsule Distributors
  9. 9.2.3 Non-animal Capsule Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst